Crossmark

Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study

Crossref DOI link: https://doi.org/10.1007/s11060-026-05572-w

Published Online: 2026-04-25

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Friedes, Cole

Berger, Melanie

Linkowski, Lauren

Hollawell, Casey

Hubbeling, Harper

Alexander, Daniel

Kurtz, Goldie

Lustig, Robert A.

Dorsey, Jay F.

Desai, Arati S.

Phillips, Richard E.

Brem, Steven

Davatzikos, Christos

Nasrallah, MacLean

O’Rourke, Donald M.

Jackson, Christina

Amankulor, Nduka M.

Alonso-Basanta, Michelle

Mohan, Suyash

Bagley, Stephen J.

Lebow, Emily S.
License Information

Text and Data Mining valid from 2026-04-25

Version of Record valid from 2026-04-25
More Information

Article History

Received: 11 March 2026

Accepted: 11 April 2026

First Online: 25 April 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below